Clinical Trial

Gastropexy as a Treatment Option for Paraesophageal Hernia

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The present proposal aims to asses which is the optimal treatment strategy in a clinical study in patients with paraoesophageal hernia (PEH), a condition often found in elderly, fragile patients The investigator want to study the optimal approach to a paraoesophageal hernia (PEH) repair. The incidence of PEH increases with age and the older patient typically has additional co-morbidities, reduced physiological fitness, and frailty which makes surgery challenging regarding increased morbidity and mortality. Thus, the decision to offer surgery can be challenging in this cohort of patients. The need of an anti-reflux procedure as part of the repair is one of the main subjects for discussion worldwide. To date no consensus exists and many surgical centres do a routine anti-reflux procedure as part of their standard operation for PEH. But is this procedure redundant? Can the patients be managed with a less complicated procedure; an anterior gastropexy with comparable outcome?
Trial Details
NCT Number NCT06096402
Lead Sponsor University Hospital of North Norway
Collaborators: Hvidovre University Hospital, St. Olavs Hospital
Conditions Paraesophageal Hernia
Enrollment 220 participants
Start Date 2024-06-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-10-23